… anticoagulant therapy (1). The fear of bleeding may explain the underuse of oral anticoagulation
… When there was no significant difference between the efficacy of DOACs in the elderly …

… Therefore, despite the overall favorable safety profile, bleeding risk remains a critical … oral
anticoagulant drug. Indeed, there are no head-to-head studies comparing safety and efficacy of …

… to compare the therapeutic effects of different oral anticoagulant drugs in AF patients with …
was a clinical trial of a treatment group (oral anticoagulant drugs) and control group, and (c) …

… Stroke prevention is the principal priority in the management of atrial fibrillation (AF); in the
presence of stroke risk factors, oral anticoagulants (OACs) are recommended to reduce this …

… of new oral anticoagulants (NOACs) offers the possibility of efficacy, relative safety and
convenience … Safety whilst using NOACs should be focused on bleeding cases, surgery or on the …

… The aim of this study was to investigate whether oral anticoagulants can provide efficacy
and safety profiles better than no anticoagulant in patients with stages 4 or 5 chronic kidney …

… For more than 50 years, vitamin K antagonists (eg, warfarin) were the only available oral
anticoagulants. It has now been 3 years since the first of the new oral anticoagulants (NOACs), …

… oral vitamin K antagonist (VKA). There has been increasing, albeit limited, evidence for the
use of direct oral anticoagulants … of studies that compared the safety and efficacy of DOACs to …

… Although conventional therapy is effective and safe, it is cumbersome … oral anticoagulants
(DOACs), which can be given in fixed doses and produce such a predictable anticoagulant …

… RCT; (II) investigating the efficacy and safety of oral anticoagulant and LMWH for the
treatment of VTE in cancer patients; and (III) a follow-up for anticoagulation therapy ≥6 months. …